Atea (NASDAQ: AVIR) grants Bruno Lucidi options and new RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Atea Pharmaceuticals director Bruno Lucidi reported equity compensation activity centered on stock awards rather than open‑market trades. He exercised 29,600 restricted stock units into Common Stock and held 142,350 Common shares directly afterward. He also received 37,700 stock options with a $4.36 exercise price and 26,700 new restricted stock units, all subject to time‑based vesting over the coming year.
Positive
- None.
Negative
- None.
Insider Trade Summary
29,600 shares exercised/converted
Mixed
4 txns
Insider
Lucidi Bruno
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 29,600 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 26,700 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 37,700 | $0.00 | -- |
| Exercise | Common Stock | 29,600 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct, null);
Stock Option (Right to Buy) — 37,700 shares (Direct, null);
Common Stock — 142,350 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Key Figures
RSUs exercised: 29,600 shares
Direct Common Stock holdings: 142,350 shares
New stock options granted: 37,700 options
+3 more
6 metrics
RSUs exercised
29,600 shares
Restricted stock units converted to Common Stock on June 18, 2026
Direct Common Stock holdings
142,350 shares
Shares directly held by Bruno Lucidi after transactions
New stock options granted
37,700 options
Right to buy Common Stock, vesting over 12 months
Option exercise price
$4.36 per share
Conversion or exercise price for 37,700 stock options
New RSUs granted
26,700 units
Restricted stock units tied to Atea Common Stock
Option expiration
June 17, 2036
Expiration date for the 37,700 stock options
Key Terms
Restricted Stock Units, Stock Option (Right to Buy), derivative security, vests, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 4.3600 per share"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vests financial
"The option vests and becomes exercisable in twelve substantially equal monthly installments"
contingent right financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
FAQ
What insider transactions did Bruno Lucidi report for Atea Pharmaceuticals (AVIR)?
Bruno Lucidi reported equity-related acquisitions only. He exercised 29,600 restricted stock units into Common Stock, received 37,700 stock options, and was granted 26,700 new restricted stock units, all as part of compensation rather than open-market buying or selling.
What are the terms of Bruno Lucidi’s new Atea Pharmaceuticals stock options?
Lucidi received 37,700 stock options with a $4.36 exercise price, each relating to one share of Common Stock. The options vest in twelve substantially equal monthly installments after June 18, 2026 and become fully vested on June 18, 2027, subject to continued service.
How do Bruno Lucidi’s new restricted stock units at Atea Pharmaceuticals vest?
He was granted 26,700 restricted stock units, each representing one potential share of Common Stock. These RSUs vest in a single installment on the earlier of the next annual stockholder meeting after June 18, 2026 or June 18, 2027, assuming he continues serving through that date.
What happened to the 29,600 restricted stock units reported in Bruno Lucidi’s Form 4?
The 29,600 restricted stock units vested in full on June 18, 2026 and were exercised into an equal number of Atea Pharmaceuticals Common shares. Following this vesting and conversion, the RSU balance for that award dropped to zero and his direct share holdings increased.